
Yilexin Biotech
宜乐芯
Yilexin Biotech
Biotech/Healthcare
Founded in August 2018, Yilexin Bio develops cost-effective clinical immunodiagnostic and molecular diagnostic systems through core technology innovation and end-to-end supply chain control, with the goal of becoming a global innovator in specialized in vitro diagnostics. The company develops and…
Latest round: Series A (2023)
Source: ChinaBulls — chinabulls.com
Last updated 2023-05-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.